- NLM Digital Collections - FDA oversightPublication: [Toronto, Ontario] : Thomson Reuters, 21-December-2020... with myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML). This represents an important advance in treatment options ... heterogeneous group of rare disorders associated with persistent eosinophilia (higher than normal levels of a type of ...
4 results